Key result
Biceps tenodesis is suggested as the preferred cost-effective treatment for type II SLAP lesions in middle-aged patients, though further health economics research is needed across age groups.
Why the study?
What is the most cost-effective treatment modality for type II SLAP lesions across different age groups?
What is the most cost-effective treatment modality for type II SLAP lesions across different age groups?
Biceps tenodesis appears to be the most cost-effective treatment for type II SLAP lesions in middle-aged patients, but further health economics research is needed for other age groups.
Type II SLAP tears are considered the most common type of SLAP lesions. However, the management of type II SLAP tears in middle-aged patients is challenging because recent evidence suggests that there is a high prevalence of type II SLAP lesions in the asymptomatic middle-aged shoulder. Treatment options for type II SLAP lesions in middle-aged patients may include biceps tenodesis, SLAP repair, or nonoperative treatment. Value-based research suggests that biceps tenodesis is the preferred cost-effective treatment modality in middle-aged patients. However, the treatment of type II SLAP lesions in younger patients is more nuanced, and isolated type II SLAP lesions in middle-aged patients are a rare, frequently misdiagnosed, and overtreated entity. As such, more work is needed to better understand the health economics of SLAP treatment across different age groups and activity levels.
No takes yet. Share an insight, caveat, or question.
Nwachukwu et al. (2018) conducted an editorial in Type II SLAP lesions. Biceps tenodesis vs. SLAP repair or nonoperative treatment was evaluated. Biceps tenodesis is suggested as the preferred cost-effective treatment for type II SLAP lesions in middle-aged patients, though further health economics research is needed across age groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: